Cheng, Y. Et Al. 2024. Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer. The New England journal of medicine , vol.391, no.14 , 1313-1327.

Cheng, Y., Spigel, D. R., Cho, B. C., Laktionov, K. K., Fang, J., Chen, Y., ... Zenke, Y.(2024). Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer. The New England journal of medicine , vol.391, no.14, 1313-1327.

Cheng, Ying Et Al. "Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer," The New England journal of medicine , vol.391, no.14, 1313-1327, 2024

Cheng, Ying Et Al. "Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer." The New England journal of medicine , vol.391, no.14, pp.1313-1327, 2024

Cheng, Y. Et Al. (2024) . "Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer." The New England journal of medicine , vol.391, no.14, pp.1313-1327.

@article{article, author={Ying Cheng Et Al. }, title={Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer}, journal={The New England journal of medicine}, year=2024, pages={1313-1327} }